Tag: research excellence medicine award

Ricardo Salas Flores | Medicine and Dentistry | Global Health Impact Award

Published on by Shen Awards

Dr. Ricardo Salas Flores | Medicine and Dentistry | Global Health Impact Award

Autonomous University of Tamaulipas | Mexico

Dr. Ricardo Salas Flores is an accomplished Pediatric Endocrinologist, clinical researcher, and academic leader with more than two decades of professional experience in pediatric endocrine disorders, diabetes, and obesity research. He currently serves as Principal Investigator at his research site, Dr. Ricardo Salas Flores Office (2011–present), and holds multiple academic roles including Full-Time Teacher and Professor of Endocrinology at the Faculty of Medicine “Dr. Alberto Romo Caballero,” Universidad Autónoma de Tamaulipas, Mexico. In addition, he serves as Clinical Health Education Coordinator and Associate Physician in Endocrinology at Hospital General No. 6 del IMSS in Ciudad Madero. Dr. Salas Flores earned a Medical Specialty in Pediatrics, followed by a Subspecialty in Pediatric Endocrinology and a Master of Medical Science from the Autonomous University of Tamaulipas. His professional qualifications are supported by national certifications, including Good Clinical Practice (CITI Program, 2020) and Digital Health Expert credentials. His clinical expertise spans metabolic disorders, pediatric diabetes, thyroid dysfunction, growth disorders, and endocrine-related chronic disease management. As a clinical researcher, Dr. Salas Flores has participated in multiple studies across Phase I to Phase IV clinical trial stages, with extensive experience in obesity-related research, including childhood obesity, fatty liver disease, and musculoskeletal health. His research scope also includes Type 1 and Type 2 diabetes, demonstrating a strong contribution to advancing endocrine care and supporting translational medical innovation. Dr. Salas Flores has collaborated with government programs, academic institutions, and industry partnerships to improve clinical practice and increase access to evidence-based endocrine care. His scientific work reflects a commitment to improving population health, strengthening pediatric care capacities, and advancing medical education in Mexico. Through his roles as educator, clinician, and researcher, he continues to mentor future healthcare professionals while contributing to the global medical community through research-driven medical practice.

Profiles: Scopus | ORCID

Featured Publications

Salas Flores, R. (2021). Alteraciones ultrasonográficas y funcionales hepáticas en niños y adolescentes con obesidad. Atención Familiar.

Salas Flores, R. (2021). Factores de riesgo asociados a retraso del crecimiento intrauterino. South Florida Journal of Development.

Salas Flores, R. (2021). Prevalencia de factores de riesgo que alteran la microbiota intestinal en niños escolares con sobrepeso y obesidad. South Florida Journal of Development.

Salas Flores, R. (2020). Conocimientos, actitudes y prácticas de los profesionales de la salud ante el VIH/SIDA en el primer nivel de atención. South Florida Journal of Development.

Salas Flores, R. (2020). Inercia terapéutica del médico familiar en pacientes con descontrol hipertensivo. South Florida Journal of Development.

Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

University of Tabuk, Saudi Arabia

Assoc. Prof. Dr. Waseem A. AlZamzami is an accomplished researcher and academic in hematopathology, molecular hematology, and cancer biology, with a strong focus on genomics, transcriptomics, metabolomics, and bioinformatics. He earned his Ph.D. in Clinical Laboratory Science from The Catholic University of America, Washington DC (2015–2022), following an M.S. in Health Sciences from Quinnipiac University, Connecticut (2013–2015), and a B.Sc. in Laboratory Medicine from Umm Al-Qurra University, Saudi Arabia (2002–2006). His professional journey includes extensive research training at the National Cancer Institute/National Institutes of Health (NCI/NIH), Bethesda, USA, where he contributed to advancing cancer genetics and translational hematology. Currently serving as an Assistant Professor of Hematology at the University of Tabuk, Saudi Arabia, he has held multiple leadership roles such as Committee Chairman for Laboratory Management, Unit Chairman for Measurement and Evaluation, and active member of Accreditation, Quality Assurance, and Curriculum Development committees. His research interests center on genetic screening, biomarker discovery, and integration of multi-omics to drive precision oncology and personalized treatment strategies. Dr. AlZamzami has authored publications in reputed journals including Discovery Medicine, Molecular Syndromology, PLOS ONE, and Cancers, with a Scopus record of 9 documents, 36 citations, and an h-index of 3, alongside three recent Saudi patents in hematological malignancies and cancer genomics. He is also a dedicated reviewer for journals such as PLOS ONE, Process Biochemistry, and International Immunopharmacology. His research skills span molecular diagnostics, bioinformatics, laboratory medicine, multi-omics analysis, and translational applications bridging bench to bedside. Recognized through international symposium presentations at NIH and national scientific forums, he has also contributed to scientific community development by mentoring students and organizing academic events. In conclusion, Dr. Waseem A. AlZamzami exemplifies a distinguished researcher whose academic excellence, innovative research, and leadership contributions to cancer biology and hematology strongly position him as a driving force in advancing precision medicine and biomedical research globally.

Profile: Scopus |ORCID| Google Scholar

Featured Publications

  1. Yan, H., Malik, N., Kim, Y. I., He, Y., Li, M., Dubois, W., Liu, H., Peat, T. J., Nguyen, J. T., … (2021). Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress. EMBO Reports, 22(6), e52122.

  2. Oyouni, A. A. A., Al-Amer, O. M., Ali, F. A. Z., Altayar, M. A., Jalal, M. M., Albalawi, R. S. M., … (2022). Melatonin ameliorates the adrenal and pancreatic alterations in streptozotocin-induced diabetic rats: Clinical, biochemical, and descriptive histopathological studies. Frontiers in Veterinary Science, 9, 1016312.

  3. Seshadri, V. D., Oyouni, A. A. A., Hawsawi, Y. M., Aljohani, S. A. S., Al-Amer, O. M., … (2022). Chemopreventive role of Tin oxide–Chitosan–Polyethylene glycol–Crocin nanocomposites against lung cancer: An in vitro and in vivo approach. Process Biochemistry, 120, 186–194.

  4. Al-Amer, O. M., Mir, R., Hamadi, A., Alasseiri, M. I., Altayar, M. A., AlZamzami, W., … (2023). Antiapoptotic gene genotype and allele variations and the risk of lymphoma. Cancers, 15(4), 1012.

  5. Vijayaragavan, P., Rathi, M. A., Gopalakrishnan, V. K., Pashameah, R. A., … (2022). CpG methylation analysis of tumour suppressor gene and expression of cathepsin B in renal cell carcinoma. Journal of King Saud University – Science, 34(8), 102330.